MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 01-14-2026
Biomerica Current Ratio 2011-2026 | BMRA
Annual Current Ratio Biomerica
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.23 | 3.48 | 5.29 | 3.73 | 4.56 | 10 | 3.56 | 5 | 7.96 | 9.55 | 8.52 | 8.84 | 9.38 | 7.58 | 6.22 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 10 | 3.23 | 6.46 |
Quarterly Current Ratio Biomerica
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.77 | 4.03 | 3.23 | 4 | 3.37 | 3.12 | 3.48 | 4.08 | 4.83 | 5.39 | 5.29 | 3.69 | 3.72 | 4.05 | 3.73 | 2.25 | 2.51 | 4.24 | 4.56 | 4.56 | 4.35 | 4.8 | 5.66 | 5.66 | 1.92 | 2.17 | 4.15 | 4.15 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 5.66 | 1.92 | 3.96 |
Current Ratio of other stocks in the Diagnostics research industry
| Issuer | Current Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
2.35 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Bioventus
BVS
|
1.5 | $ 9.24 | 2.72 % | $ 616 M |  USA |
|
Biodesix
BDSX
|
1.27 | $ 15.58 | 6.06 % | $ 2.02 B | USA |
 |
Fulgent Genetics
FLGT
|
13.4 | $ 16.29 | -0.28 % | $ 493 M | USA |
 |
Guardant Health
GH
|
0.953 | $ 83.67 | -1.52 % | $ 10.5 B | USA |
 |
IDEXX Laboratories
IDXX
|
1.92 | $ 573.49 | -0.87 % | $ 46.1 B | USA |
|
Akumin
AKU
|
1.09 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Lantheus Holdings
LNTH
|
1.96 | $ 74.3 | -1.89 % | $ 5.01 B | USA |
 |
Enzo Biochem
ENZ
|
2.89 | - | -8.98 % | $ 14.8 K | USA |
 |
Medpace Holdings
MEDP
|
1.3 | $ 464.6 | 1.68 % | $ 13.4 B | USA |
 |
Check-Cap Ltd.
CHEK
|
0.206 | - | - | $ 9.42 M |  Israel |
 |
Myriad Genetics
MYGN
|
2.09 | $ 4.68 | 0.54 % | $ 433 M | USA |
 |
National Research Corporation
NRC
|
1.12 | $ 17.21 | -1.71 % | $ 385 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
15.6 | - | - | $ 562 M |  Britain |
 |
Pacific Biosciences of California
PACB
|
1.01 | $ 1.39 | - | $ 417 M | USA |
 |
DermTech
DMTK
|
1.88 | - | -11.32 % | $ 2.94 M | USA |
 |
Aspira Women's Health
AWH
|
1.63 | - | -6.19 % | $ 10.5 M | USA |
 |
Precipio
PRPO
|
4.93 | $ 27.01 | 0.3 % | $ 35.1 M | USA |
 |
Personalis
PSNL
|
4.02 | $ 7.78 | 2.23 % | $ 461 M | USA |
 |
Co-Diagnostics
CODX
|
10.2 | $ 4.4 | 101.83 % | $ 129 M | USA |
 |
Accelerate Diagnostics
AXDX
|
0.745 | - | -61.36 % | $ 2.46 M | USA |
 |
RadNet
RDNT
|
1.56 | $ 59.45 | -3.71 % | $ 4.47 B | USA |
 |
Global Cord Blood Corporation
CO
|
2.34 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
2.17 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
4.76 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
2.28 | - | 0.12 % | $ 80.1 M | China |
 |
Senseonics Holdings
SENS
|
1.94 | $ 6.7 | 1.21 % | $ 280 M | USA |
 |
Sotera Health Company
SHC
|
1.23 | $ 13.87 | -0.11 % | $ 3.94 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.15 | - | - | $ 10.7 B | USA |
 |
Soleno Therapeutics
SLNO
|
4.96 | $ 31.01 | -2.25 % | $ 1.58 B | USA |
 |
Charles River Laboratories International
CRL
|
1.82 | $ 159.89 | 1.2 % | $ 7.92 B | USA |
 |
IQVIA Holdings
IQV
|
1.28 | $ 167.87 | 0.55 % | $ 28.9 B | USA |
 |
Neuronetics
STIM
|
1.23 | $ 1.49 | -6.88 % | $ 98.3 M | USA |
 |
Biocept
BIOC
|
1.4 | - | -13.05 % | $ 7.29 M | USA |
 |
Invitae Corporation
NVTA
|
1.05 | - | - | $ 21.2 M | USA |
 |
BioNano Genomics
BNGO
|
2.52 | $ 1.19 | -18.49 % | $ 6.48 M | USA |
 |
Mettler-Toledo International
MTD
|
0.994 | $ 1 264.65 | 2.06 % | $ 26.1 B |  Schweiz |
 |
Interpace Biosciences
IDXG
|
0.87 | $ 1.71 | 0.73 % | $ 7.5 M | USA |
 |
Illumina
ILMN
|
6.69 | $ 125.94 | 1.74 % | $ 20 B | USA |
 |
Twist Bioscience Corporation
TWST
|
3.8 | $ 46.98 | 5.57 % | $ 2.81 B | USA |
 |
QIAGEN N.V.
QGEN
|
1.88 | - | - | $ 10.6 B |  Niderland |
 |
Celcuity
CELC
|
1.89 | $ 102.11 | -4.35 % | $ 4.03 B | USA |
 |
Chembio Diagnostics
CEMI
|
1.4 | - | 0.22 % | $ 16.8 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
1.89 | $ 266.04 | 0.61 % | $ 22.1 B | USA |
 |
Motus GI Holdings
MOTS
|
1.59 | - | -34.28 % | $ 263 K | Israel |
 |
ENDRA Life Sciences
NDRA
|
2.35 | $ 3.49 | 0.29 % | $ 1.87 M | USA |
 |
NeoGenomics
NEO
|
2.6 | $ 7.92 | -2.28 % | $ 1.01 B | USA |
 |
Natera
NTRA
|
2.02 | $ 195.76 | -2.17 % | $ 19.3 B | USA |
 |
CareDx, Inc
CDNA
|
3.75 | $ 17.83 | 1.54 % | $ 950 M | USA |
 |
OPKO Health
OPK
|
2.64 | $ 1.12 | -2.61 % | $ 777 M | USA |